Active substances
Kaolin + Pectin
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| KAPECT SUSP. | 193,4.3 mg/ml,mg/ml | Suspension · Oral use | 1 Bottle | SAR 9.30 | Generic · OTC | EIPICO | Valid |
| DEFOPECT SUSPENSION | 193, 4.3 g/ml | Oral suspension · Oral use | 1 Bottle | SAR 5.60 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| KAPTIN SUSP | 1972,4.4 mg/ml,mg/ml | Oral suspension · Oral use | 1 Bottle | SAR 6.20 | NCE · OTC | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
DIARRHEA
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.